<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04886882</url>
  </required_header>
  <id_info>
    <org_study_id>SakuraDermatology1</org_study_id>
    <nct_id>NCT04886882</nct_id>
  </id_info>
  <brief_title>Topical Agents Containing Magnesium Sulfate &amp; Wound Healing in the Rat Model</brief_title>
  <official_title>The Effect of Topical Agents in Cream Formations Containing Magnesium Sulfate on Wound Healing in the Rat Model</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Basaksehir Cam &amp; Sakura Şehir Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istanbul Kent University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Basaksehir Cam &amp; Sakura Şehir Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An experimental study examining wound healing in 5 different groups on 30 rats.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Magnesium topically increases collagen synthesis and angiogenesis, providing faster and&#xD;
      higher quality wound healing. In addition, with its analgesic effect, it will also eliminate&#xD;
      the pain sensation caused by the wound and increase the quality of life of the patient whose&#xD;
      skin integrity is impaired.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 22, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>7th day evaluation</measure>
    <time_frame>7th day</time_frame>
    <description>Histopathological evaluation of wound healing comparing with the rate of vascular endothelial growth factor (VEGF), transforming growth factor (TGF-beta) and hydroxyproline at immunohistochemical staining with biopsy on the 7th day.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>15th day evaluation</measure>
    <time_frame>15th day</time_frame>
    <description>Histopathological evaluation of wound healing comparing with the rate of VEGF, TGF-beta and hydroxyproline at immunohistochemical staining with biopsy on the 15th day.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Wound Heal</condition>
  <arm_group>
    <arm_group_label>Group placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Isotonic solution will be administered daily to 6 female rats.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Base cream to be applied twice a day to 6 female rats.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group %1 mgso4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cream containing 1% MgSO4 will be applied twice a day to 6 female rats.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group %10 MgSO4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cream containing 10% MgSO4 will be applied twice a day to 6 female rats.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group positive control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cream containing centella asiatica will be applied twice a day to 6 female rats.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo comparator</intervention_name>
    <description>solution containing 0.9 % sodium chlorine</description>
    <arm_group_label>Group placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sham comparator</intervention_name>
    <description>vaseline, beeswax,polyglyceryl-3 diisostearate, sorbitan caprylate, propandiol,benzoic acid, glycerin, water</description>
    <arm_group_label>Group sham</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental drug 1</intervention_name>
    <description>A cream containing 10 % MgSO4.vaseline, beeswaxpolyglyceryl-3 diisostearate, sorbitan caprylate, propandiol,benzoic acid, glycerin, water</description>
    <arm_group_label>Group %1 mgso4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental drug 2</intervention_name>
    <description>A cream containing 10 % MgSO4.vaseline, beeswax,polyglyceryl-3 diisostearate, sorbitan caprylate, propandiol,benzoic acid, glycerin, water</description>
    <arm_group_label>Group %10 MgSO4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Centella asiatica</intervention_name>
    <description>A cream containing Centella asiatica</description>
    <arm_group_label>Group positive control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy rats between ages of 8- 12 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  weight loss of more than 15% of body weight&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>8 Weeks</minimum_age>
    <maximum_age>12 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Başakşehir Çam Ve Sakura Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>May 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2021</study_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>magnesium sulphate</keyword>
  <keyword>wound healing rat model</keyword>
  <keyword>hydroxyproline</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

